Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Cardiovascular Catch-Up: Medtronic And Edwards Make Headlines At TCT Conference

Nov 16 2021

• By Reed Miller

3d rendered medically accurate illustration of the tricuspid valve — • Source: Shutterstock

Related Content

US FDA Green-Lights Medtronic's CoreValve Evolut For Intermediate Risk

Jul 11 2017

FDA Expands TAVR Indication To Low-Risk Patients

Aug 16 2019

Work With Patients To Design Trials For Anti-Hypertensive Devices, FDA Advisors Suggest

Dec 06 2018

Cardiovascular Catch-Up: Spring Brings Bloom Of New Clinical Trial Results And Launches

Jun 11 2021

Medtronic Pushes Completion Of Pivotal Renal Denervation Trial To Late 2022

Oct 18 2021

EuroPCR 2018: Medtronic RDN Rises Out Of Ashes With Positive SPYRAL Data

May 23 2018

Abbott Becomes Third US TAVR Competitor With Portico Approval

Sep 20 2021

Medtronic Launches Trial Of Tricuspid Version Of Intrepid Transcatheter Valve

Sep 09 2020

ACC 2020: TAVR Matches Surgery In Two-Year PARTNER 3 Results

Apr 03 2020

Related Companies

Medtronic plc

Additional Topics

Clinical Trials Research & Development Cardiovascular Cardiology Medical Device

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Medtech Top 100 Ranking
Data Trackers
FDA Warning Letters

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window